This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Eric Matthew Bell: Innovator in Individualized Medicine
Introduction
Eric Matthew Bell is an innovative inventor based in the United States. He has made significant contributions to the field of individualized medicine, focusing on the integration of technology and healthcare. His work aims to enhance the procurement of personalized medical therapies through advanced systems and methods.
Latest Patents
Eric Matthew Bell holds a patent for a "Centralized And Decentralized Individualized Medicine Platform." This patent relates to systems, devices, and methods for executing operations associated with the procurement of individualized medicine therapies. The disclosed systems and methods also include embodiments that access a wide range of individualized medicine platform modules. Furthermore, these systems are communicatively coupled to blockchain computing systems, generating chain of custody and chain of identity event data.
Career Highlights
Eric is currently employed at Vineti Inc., where he continues to develop innovative solutions in the healthcare sector. His work focuses on creating platforms that facilitate individualized medicine, which is crucial for improving patient outcomes. Despite having no patents attributed to him, his contributions to the field are noteworthy.
Collaborations
Eric collaborates with talented professionals such as Khurram Mahmood and Richard Brewster Wickersham. These partnerships enhance the development of cutting-edge technologies in individualized medicine.
Conclusion
Eric Matthew Bell is a dedicated inventor whose work in individualized medicine showcases the potential of technology in transforming healthcare. His innovative approach and collaboration with industry professionals position him as a key figure in this evolving field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
